Compare Suven Life Sciences with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES DR. REDDYS LAB SUVEN LIFE SCIENCES/
DR. REDDYS LAB
 
P/E (TTM) x -95.5 41.1 - View Chart
P/BV x 1.5 5.6 26.7% View Chart
Dividend Yield % 1.5 0.5 324.6%  

Financials

 SUVEN LIFE SCIENCES   DR. REDDYS LAB
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-19
DR. REDDYS LAB
Mar-20
SUVEN LIFE SCIENCES/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3383,363 10.0%   
Low Rs1692,352 7.2%   
Sales per share (Unadj.) Rs52.11,054.2 4.9%  
Earnings per share (Unadj.) Rs6.8121.9 5.6%  
Cash flow per share (Unadj.) Rs8.6190.2 4.5%  
Dividends per share (Unadj.) Rs1.5025.00 6.0%  
Dividend yield (eoy) %0.60.9 67.6%  
Book value per share (Unadj.) Rs65.3938.7 7.0%  
Shares outstanding (eoy) m127.28166.17 76.6%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.92.7 179.4%   
Avg P/E ratio x37.123.4 158.4%  
P/CF ratio (eoy) x29.615.0 196.9%  
Price / Book Value ratio x3.93.0 127.6%  
Dividend payout %22.020.5 107.1%   
Avg Mkt Cap Rs m32,272474,831 6.8%   
No. of employees `0001.121.7 5.0%   
Total wages/salary Rs m66133,802 2.0%   
Avg. sales/employee Rs Th6,132.28,091.0 75.8%   
Avg. wages/employee Rs Th611.11,561.3 39.1%   
Avg. net profit/employee Rs Th803.5935.8 85.9%   
INCOME DATA
Net Sales Rs m6,635175,170 3.8%  
Other income Rs m2426,206 3.9%   
Total revenues Rs m6,877181,376 3.8%   
Gross profit Rs m1,60424,421 6.6%  
Depreciation Rs m22111,348 2.0%   
Interest Rs m38983 3.8%   
Profit before tax Rs m1,58718,296 8.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m0561 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718-1,403 -51.2%   
Profit after tax Rs m86920,260 4.3%  
Gross profit margin %24.213.9 173.4%  
Effective tax rate %45.2-7.7 -589.8%   
Net profit margin %13.111.6 113.3%  
BALANCE SHEET DATA
Current assets Rs m6,232125,991 4.9%   
Current liabilities Rs m1,49072,141 2.1%   
Net working cap to sales %71.530.7 232.5%  
Current ratio x4.21.7 239.5%  
Inventory Days Days8673 118.3%  
Debtors Days Days83105 78.8%  
Net fixed assets Rs m4,04383,854 4.8%   
Share capital Rs m127831 15.3%   
"Free" reserves Rs m8,183155,157 5.3%   
Net worth Rs m8,310155,988 5.3%   
Long term debt Rs m181,304 1.4%   
Total assets Rs m10,389232,253 4.5%  
Interest coverage x43.119.6 219.8%   
Debt to equity ratio x00 25.6%  
Sales to assets ratio x0.60.8 84.7%   
Return on assets %8.79.1 95.5%  
Return on equity %10.513.0 80.6%  
Return on capital %19.512.6 154.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,62284,193 6.7%   
Fx outflow Rs m1,79939,616 4.5%   
Net fx Rs m3,82244,577 8.6%   
CASH FLOW
From Operations Rs m35629,841 1.2%  
From Investments Rs m-279-4,923 5.7%  
From Financial Activity Rs m-225-25,159 0.9%  
Net Cashflow Rs m-148-266 55.7%  

Share Holding

Indian Promoters % 63.4 25.5 248.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 5.4 -  
FIIs % 0.0 35.3 -  
ADR/GDR % 0.0 18.5 -  
Free float % 36.5 15.3 238.6%  
Shareholders   37,287 75,885 49.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   FDC  UNICHEM LAB  WYETH  AJANTA PHARMA  ALEMBIC  

Compare SUVEN LIFE SCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Snap 4-Day Winning Streak; JSW Steel and Hindalco Among Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

More Views on News

Most Popular

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SCIENCES SHARE PRICE


May 11, 2021 (Close)

TRACK SUVEN LIFE SCIENCES

  • Track your investment in SUVEN LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE SCIENCES

SUVEN LIFE SCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFE SCIENCES WITH

MARKET STATS